Our assumption is in line with previous in vivo studies, showing that oral annatto TT supplementation prevented osteopenia induced by metabolic syndrome by reducing SOST and DKK1 levels, considered antagonist of the Wnt signalling pathway [33]. The gene discussed is DKK1; the disease is metabolic syndrome.